Literature DB >> 16534682

Risk factors for the transmission of hepatitis C virus infection in the Turkish population.

Cetin Karaca1, Yilmaz Cakaloğlu, Kadir Demir, Sadakat Ozdil, Sabahattin Kaymakoğlu, Selim Badur, Atilla Okten.   

Abstract

The risk factors for the transmission of hepatitis C virus (HCV) infection varies substantially between countries and geographic regions. The aim of this investigation was to determine the risk factors which may be involved in the transmission of HCV infection in the Turkish population. This study included patients who were admitted to the Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, between 1996 and 2002 and found to be anti-HCV positive during hospitalization or during follow-up as outpatients. All patients were asked about risk factors for HCV transmission including transfusion, history of operation, hospitalization, hemodialysis, intravenous drug use, suspected sexual contact, tattooing, acupuncture, dental procedures, manicure and pedicure, blood brotherhood rituals, perinatal risk factors, common circumcision rituals, and history of abortion. In our study, total of 320 patients with anti-HCV seropositivity were involved. The numbers and percentages of male and female patients were 139 (43.4%) and 181 (56.6%), respectively. The mean age of the patients was 49.7+/- 12.4 years (range: 18-73 years). HCV-RNA was found to be positive in 297 (92.8%) patients. The most common risk factor was a history of surgery (305; 98%), and the second most common was blood transfusion (123; 39.7%). The numbers and percentages of patients for the other risk factors were as follows: dental procedure, 86 (27.5%); abortion, 66 (21.2%); long-term hospitalization, 37 (11.6%); hemodialysis, 31 (10%); history of jaundice, 15 (4.6%); history of intravenous drug abuse, 10 (3.1%); history of suspected sexual contact, 5 (1.5%); history of manicure and pedicure, 4 (1.2%); history of occupational transmission, 3 (0.9%); history of tattooing, 2 (0.6%); history of acupuncture, 2 (0.6%); circumcision in a common circumcision ritual, 1 (0.3%); and percutaneous needle puncture, 1 (0.3%). None of the patients had a history of blood brotherhood ritual or perinatal transmission. Only one risk factor was detected in 73 (22.8%) patients, two risk factors were detected in 122 (38.2%) patients, three risk factors were detected in 78 (24.5%) patients, and four risk factors were detected in 39 (12.2%) patients, however, in 8 (1.6%) patients no risk factors could be found. In Turkey, the most common risk factor for the transmission of HCV infection is surgery, which can be preventable.

Entities:  

Mesh:

Year:  2006        PMID: 16534682     DOI: 10.1007/s10620-006-3139-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Patient-to-patient transmission of hepatitis C virus during colonoscopy.

Authors:  J P Bronowicki; V Venard; C Botté; N Monhoven; I Gastin; L Choné; H Hudziak; B Rihn; C Delanoë; A LeFaou; M A Bigard; P Gaucher; B Rhin
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

Review 2.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 3.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Nosocomial transmission of hepatitis C virus.

Authors:  R Schvarcz; B Johansson; B Nyström; A Sönnerborg
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

5.  Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin.

Authors:  J P Power; E Lawlor; F Davidson; P L Yap; E Kenny-Walsh; M J Whelton; T J Walsh
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

6.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

7.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

8.  Transmission of hepatitis C virus by a cardiac surgeon.

Authors:  J I Esteban; J Gómez; M Martell; B Cabot; J Quer; J Camps; A González; T Otero; A Moya; R Esteban
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

9.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  6 in total

Review 1.  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Authors:  Soheil Ashkani-Esfahani; Seyed Moayed Alavian; Mohammad Salehi-Marzijarani
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 2.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

3.  Prioritizing High-Risk Practices and Exploring New Emerging Ones Associated With Hepatitis C Virus Infection in Egypt.

Authors:  Ammal Metwally; Amira Mohsen; Rehan Saleh; Walaa Foaud; Nihad Ibrahim; Thanaa Rabaah; Manal El-Sayed
Journal:  Iran J Public Health       Date:  2014-10       Impact factor: 1.429

4.  Low Prevalence of Hepatitis C Virus Infection Among HIV-Positive Patients: Data From a Large-Scale Cohort Study in Istanbul, Turkey.

Authors:  Ozlem Altuntas Aydin; Mucahit Yemisen; Hayat Kumbasar Karaosmanoglu; Fatma Sargin; Alper Gunduz; Bahadir Ceylan; Bilgul Mete; Nail Ozgunes; Dilek Yildiz Sevgi; Resat Ozaras; Fehmi Tabak
Journal:  Hepat Mon       Date:  2014-08-16       Impact factor: 0.660

5.  [Manicure and pedicure in the city of Ouagadougou (Burkina Faso): practices and risks].

Authors:  Nina Korsaga-Somé; Jean Baptiste Andonaba; Muriel Sidnoma Ouédraogo; Gilbert Patrice Tapsoba; Léopold Ilboudo; Cérina Savadogo; Fatou Barro-Traoré; Pascal Niamba; Adama Traoré
Journal:  Pan Afr Med J       Date:  2016-05-31

6.  Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital.

Authors:  Charles Asabamaka Onyekwere; Anthonia O Ogbera; Akinola Olusola Dada; Olufunke O Adeleye; Adedoyin O Dosunmu; Akinsegun A Akinbami; Bodunrin Osikomaiya; Oladipupo Hameed
Journal:  Hepat Mon       Date:  2016-05-01       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.